Clever Culture Systems is owned by LBT Innovations (ASX:LBT). 

Clever Culture Systems is a leader in clinical microbiology technology, delivering modular automation solutions that maximise laboratory efficiency. Our technologies are designed by microbiologists for microbiologists to ensure our products not only meet the needs of the laboratory but also seamlessly
integrate within our customer’s workflow. Our team are highly experienced in biotechnology, laboratory automation, diagnostics and microbiology.

THE CLEVER WAY TO AUTOMATE PLATE READING

The market-leading, innovative technology streamlines busy laboratory workflows, offering a modular approach. 

The APAS Independence is a stand-alone automated culture plate reading instrument that accurately and efficiently screens and sorts significant and insignificant growth plates at a rate of 200 plates per hour. The modular system ensures you only pay for what you need. Choose from urine, infection control (antibiotic resistance), respiratory and MRSA modules. The innovative, FDA cleared culture plate classification system identifies negative plates, allowing microbiologists to focus on the positive and significant growth plates that require their time and expertise, accelerating patient diagnosis.


AI/ML

Automation

Health Data

Clever Culture Systems

Org chart

Similar companies